Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents: a meta-analysis

Chun Shing Kwok, Heerajnarain Bulluck, Alisdair D Ryding, Yoon K Loke

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is unclear.
Original languageEnglish
Article number794078
JournalThe Scientific World Journal
Volume2014
DOIs
Publication statusPublished - 2014

Cite this